Under-representation of the elderly in cancer clinical trials

Cancer predominantly affects the elderly, but those over 65 years of age are significantly and consistently under-represented in clinical trials of potential new treatments. How important is this to cancer care in the elderly, are there identifiable reasons for the disparity and can anything be done...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of hospital medicine (London, England : 2005) Vol. 71; no. 12; p. 678
Main Authors Lang, Kathryn J, Lidder, Surjit
Format Journal Article
LanguageEnglish
Published England 01.12.2010
Subjects
Age Factors
Aged
Attitude of Health Personnel
Attitude to Health
Clinical Trials as Topic
Humans
Neoplasms - therapy
Patient Selection
Online AccessGet more information

Cover

More Information
Summary:Cancer predominantly affects the elderly, but those over 65 years of age are significantly and consistently under-represented in clinical trials of potential new treatments. How important is this to cancer care in the elderly, are there identifiable reasons for the disparity and can anything be done to redress the imbalance?
ISSN:1750-8460
DOI:10.12968/hmed.2010.71.12.678